my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
09-01-2009: Genencor, a division of Danisco A/S and BRAIN AG join forces in the field of the biobased fermentative production of industrially relevant biochemicals from renewable raw materials. Genencor will use its capabilities in metabolic pathway engineering and biomanufacturing of industrial bio-products and BRAIN AG’s expertise in the fields of metagenomics and screening technologies, to pursue product targets for the chemical industry.
BRAIN will provide Genencor access to these technologies and especially to its metagenome resources of some150 million genes of yet uncultured microorganisms. Enzymes and biosynthetic pathways of interest will then be genetically engineered in microbial production strains for the production of important biochemicals.
This new collaboration expands upon the successful collaboration first established in 2004, where the two companies joined forces to develop a new enzyme product platform.
Contact / Request information
Request further information free of charge:
Watchlist
This is where you can add this news to your personal favourites
BRAIN-led industrial NatLifE 2020 innovation alliance started after receipt of approval
As the industrial coordinator of the innovation alliance, the biotechnology company BRAIN AG has announced that the Natural Life Excellence Network 2020 (NatLifE 2020) innovation alliance is the first alliance to receive the official approval letter under the “Industrial Biotechnology Innov ... more
BRAIN expands its IP Portfolio with bioactive Compound MMPI
BRAIN AG has announced the expansion of its IP portfolio to include the MMPI (matrix metalloproteinase inhibitor) peptide. Now owned by BRAIN, the recombinant human bioactive molecule will be manufactured by BRAIN as a proprietary bioactive compound going forward and exclusively used in cos ... more
BRAIN announces €60m round of financing to expand its buy-and-build strategy
The supervisory board and the board of management of the biotechnology company BRAIN AG agreed on a €60m capital increase during a meeting of the supervisory board held on 19 November 2012. The capital increase helps pave the way for the implementation of BRAIN’s “buy-and-build” industriali ... more
BRAIN Biotechnology Research And Information Network AG
BRAIN AG is an industrial “white” biotech company which discovers and develops novel bioactive natural compounds and proprietary enzymes for its partners and customers in the chemical and pharmaceutical industries, as well as the food and cosmetics industries. With its unique approach to th ... more
DuPont to Acquire Danisco for $6.3 Billion
DuPont recently announced it had entered into a definitive agreement for the acquisition of Danisco for $5.8 billion in cash and assumption of $500 million of Danisco net debt. “Danisco is a premier company, a long-time successful partner of DuPont and a proven innovator committed to sus ... more
ProteoNic and Genencor Sign Research Agreement
ProteoNic and Genencor, a Danisco Division, have signed a research agreement. As part of the contract, the two biotech companies will use ProteoNic’s UNic™ Toolbox to investigate enzyme production for Genencor’s fungal expression platforms. ProteoNic will support Genencor in applying the un ... more
Strategic Collaboration between Genencor and BRAIN
Genencor, a division of Danisco A/S and BRAIN AG join forces in the field of the biobased fermentative production of industrially relevant biochemicals from renewable raw materials. Genencor will use its capabilities in metabolic pathway engineering and biomanufacturing of industrial bio-pr ... more
Danisco offers a comprehensive range of ingredients for the food industry and other industrial sectors, for example the feed and plastics industries. more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
